High -quality development of the Chinese medicine industry has entered the fast lane

Zhang Ying

"Inheritance essence, keeping positive innovation." A series of major decision -making deployments since the 18th National Congress of the Communist Party of China have placed traditional Chinese medicine as a treasure of Chinese culture in a more prominent position, and the direction of the pulse and the direction of the inheritance and innovation development. Now the traditional Chinese medicine industry is ushered in highlights.

"In terms of improving the policy system, the Party Central Committee and the State Council attach great importance to support. Over the press conference, the National Traditional Chinese Medicine Administration's Policy and Regulations and Supervision Department of the State Administration of Traditional Chinese Medicine said so much that the Chinese medicine policy system and the improvement of service capabilities were expressed.

In recent years, the Chinese medicine industry has entered a golden period of development. The policy system and top -level design have been perfect. Among the many "first", the high -quality development road of the Chinese medicine industry has become more and more smooth, and has entered the fast track of development.

On December 6, 2016, the State Council News Office published the white paper of "Chinese Chinese Medicine" as the first white paper in my country to release the development of traditional Chinese medicine, which showed the world the policy and achievement of Chinese medicine to develop Chinese medicine.

On July 1, 2017, the "Traditional Chinese Medicine Law of the People's Republic of my country" was officially implemented. This is the first basic and programmatic law in the field of Chinese medicine in China.

On December 16, 2019, for the first time, the "Opinions of the Central Committee of the Communist Party of China and the State Council of the Central Committee of the Communist Party of China on Promoting the Innovation and Development of TCM inheritance and Innovation and Development in the name of the State Council and the State Council, from the high degree of the development of the party and the country's development, made a comprehensive and strategic and strategic work of traditional Chinese medicine. Systemic arrangement.

In March of this year, the General Office of the State Council issued the "Fourteenth Five -Year Plan" Traditional Chinese Medicine Development Plan "pointed out that by 2025, the ability of traditional Chinese medicine health service capabilities will be significantly enhanced, the high -quality development policy and system of traditional Chinese medicine will be further improved. The results of the results are fully exerted in the unique advantages of healthy China.

In addition, on July 29, the Securities and Futures Commission announced the "Corporate Information Disclosure and Report Rules No. 25 of the Public Issuance of Securities -Council of the Prospectus of the Company Prospectus in the Drug and Medical Device Business" and implemented it from the date of announcement. This will undoubtedly provide convenience for pharmaceutical companies.

As Yu Haiyang said, the supply of traditional Chinese medicine policy is more comprehensive and powerful. It has both the strategic arrangements of the party and the state's overall and high degree of strategic arrangements, as well as legal requirements. , Three -dimensional, multi -level and more mature policy system, focusing on promoting the inheritance and innovation development of Chinese medicine in the new era, the contribution of Chinese medicine to economic and social development has been significantly improved. More solid.

According to statistics from the national pharmaceutical industry, the traditional Chinese medicine industry increased steadily in 2021, with annual operating income of 691.9 billion yuan, an increase of 12.4%year -on -year. In 2021, the total profit of traditional Chinese medicine industry was 100.45 billion yuan, an increase of 37%year -on -year. It can be said that while Chinese medicine has contributed hugely for human health, the Chinese medicine industry has also become my country's new economic growth point.

The Chinese medicine sector is also respected by investors. Policy support, performance -driven, and relatively low valuations are the three -layer logic of investors investing in the sector. As of the closing of August 2, the total market value of 73 Chinese medicine listed companies in the A -share market totaling a total of 932.174 billion yuan; the latest dynamic price -earnings ratio of the Chinese medicine sector was 24.98 times, which was lower than the latest dynamic price -earnings ratio (31.06 times) lower than the pharmaceutical and biological industry. Essence

The road is long, and the line is coming. It is believed that the Chinese medicine industry will play a more important role in economic and social development under policy and capital blessings.

- END -